Crossmark

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion

Crossref DOI link: https://doi.org/10.1128/JVI.01429-16

Published Print: 2016-10

Update policy: https://doi.org/10.1128/asmj-crossmark-policy-page

Authors

Coleman, Christopher M.

Sisk, Jeanne M.

Mingo, Rebecca M.

Nelson, Elizabeth A.

White, Judith M.

Frieman, Matthew B.
Funding

Funding for this research was provided by:

HHS | NIH | National Institute of Allergy and Infectious Diseases (AI095569)

HHS | NIH | National Institute of Allergy and Infectious Diseases (R21AI103601, R01AI114776)

HHS | NIH | National Institute of Allergy and Infectious Diseases (AI118303)
License Information

Text and Data Mining valid from 2016-10-01
More Information

Publication History

Received: 2016-07-18

Accepted: 2016-07-18

Published: 2016-09-12

Document is current

Any future updates will be listed below